Nate Silver looks at the Hall of Fame voting

38 Comments

Nate Silver — with a strong assist from @leokitty, who has compiled a spreadsheet of public Hall of Fame votes — gives those public Hall of Fame votes the old Nate Silver treatment in his latest post.

Specifically, he looks for patterns among voters who did and didn’t vote for Barry Bonds and/or Roger Clemens in an attempt to see what that means for others on the ballot. The upshot: while Bonds and Clemens represent a clear and unambiguous case of voters weighing in on the steroid era for good or for ill, the suction is taking guys like Bagwell and Piazza down with them.  Which, if you’re not yet sick of my Hall of Fame posts here, you’re well aware of.

Silver notes, however, that that suction, well, sucks, because it’s based on some pretty crude and inaccurate stereotyping by the electorate. Because — based on the sorts of players who have been suspended for performance-enhancing drugs, it makes little sense to simply assume use by the big guys and assume that the little guys were clean:

Among these players are the utility infielder Neifi Perez, who hit 64 home runs in a 12-year career, the slap-hitting outfielder Jorge Piedra, and a substantial number of pitchers. The incidence of performance-enhancing drug use seems to be fairly randomly distributed between stars and benchwarmers, players at different positions and those with different skills.

Some writers seem to think they can profile steroid users, and some otherwise-deserving players seem likely to be denied a place in Cooperstown because of it.

Brewers to give Mike Moustakas a look at second base

Thearon W. Henderson/Getty Images
8 Comments

The Brewers reportedly signed third baseman Mike Moustakas to a one-year, $10 million contract on Sunday. While the deal is not yet official, MLB.com’s Adam McCalvy reports that the Brewers plan to give Moustakas a look at second base during spring training. If all goes well, he will be the primary second baseman and Travis Shaw will stay at third base.

The initial thought was that Moustakas would simply take over at third base for the more versatile Shaw. Moustakas has spent 8,035 of his career defensive innings at third base, 35 innings at first base, and none at second. In fact, he has never played second base as a pro player. Shaw, meanwhile, has spent 268 of his 4,073 1/3 defensive innings in the majors at second base and played there as recently as October.

This is certainly an interesting wrinkle to signing Moustakas, who is a decent third baseman. He was victimized by another slow free agent market, not signing until March last year on a $6.5 million deal with a $15 million mutual option for this season. That option was declined, obviously, and he ended up signing for $5 million cheaper here in February as the Brewers waited him out. Notably, Moustakas did not have qualifying offer compensation attached to him this time around.

Last season, between the Royals and Brewers, the 30-year-old Moustakas hit .251/.315/.459 with 28 home runs and 95 RBI in 635 plate appearances.